Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Assets: 2010-2025

Historic Assets for Sunshine Biopharma (SBFM) over the last 12 years, with Sep 2025 value amounting to $31.5 million.

  • Sunshine Biopharma's Assets rose 4.76% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 million, marking a year-over-year increase of 4.76%. This contributed to the annual value of $30.6 million for FY2024, which is 11.75% up from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Assets is $31.5 million, which was down 1.49% from $32.0 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Assets registered a high of $42.0 million during Q2 2022, and its lowest value of $1.8 million during Q2 2021.
  • Moreover, its 3-year median value for Assets was $29.3 million (2024), whereas its average is $29.5 million.
  • Per our database at Business Quant, Sunshine Biopharma's Assets surged by 2,818.08% in 2021 and then tumbled by 32.34% in 2023.
  • Sunshine Biopharma's Assets (Quarterly) stood at $2.2 million in 2021, then surged by 1,227.52% to $29.2 million in 2022, then declined by 6.49% to $27.3 million in 2023, then increased by 11.75% to $30.6 million in 2024, then climbed by 4.76% to $31.5 million in 2025.
  • Its last three reported values are $31.5 million in Q3 2025, $32.0 million for Q2 2025, and $29.2 million during Q1 2025.